Publication: 3724

Publication: 3724

Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy with or without Immunotherapy for Peritoneal Mesothelioma (Alliance: A092001)

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 40 (16_suppl) TPS8598

Meeting Instance:: ASCO 2022
Year:: 2022
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Experimental
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171

Corr. Author:
Authors:: Aaron Mansfield Austin Goodrich Nathan Foster Vinicius Ernani Liza Villaruz Patrick Forde Kanwal Raghav Paul Romesser Krista Garbacz Liang Cao Mary Salvatore Anja Roden Steven Powell Ardaman Shergill Pamela Munster Gary Schwartz Travis Grotz

Networks:: CA824, COLUMBIA, LAPS-IL057, LAPS-MD017, LAPS-MN026, LAPS-NY016, LAPS-PA015, LAPS-TN008, LAPS-TX035, SANFORD

Study: Alliance-A092001
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: